News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Nico Gagelmann/X
Jan 19, 2025, 22:11

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X about a recent paper by him and colleagues published in HemaSphere:

“Finally published!

Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma.”

“Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study”

Authors: Maximilian Merz, Anca-Maria Albici, Bastian von Tresckow, Thomas Pabst, Nico Gagelmann et al.

Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma

More posts featuring Nico Gagelmann.

Anca-Maria Albici Bastian von Tresckow cancer Maximilian Merz multiple myeloma Nico Gagelmann OncoDaily Oncology Thomas Pabst
Special Coverage
Library
Feb 21, 2025, 16:41
New Paper Alert: Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach
Blog
Feb 21, 2025, 15:06
The full press release of ELLOK is out
Blog
Feb 21, 2025, 14:59
Siobhan Freeney: What women in Ireland need to know about Dense Breasts and Cancer
Blog
Feb 21, 2025, 14:54
CEO of the Canadian Cancer Society about the inequities in cancer care across populations in Canada - UICC
Career
Feb 21, 2025, 14:34
Kristiyana Kaneva is appointed as Medical Director of Oncology Early Development at AbbVie
Blog
Feb 21, 2025, 14:27
Douglas Flora: A Cure for Cancer - Closer Than We Think?
Blog
Feb 21, 2025, 14:26
14th Biennial Childhood Leukemia and Lymphoma Symposium: Advancing Research and Collaboration in Budapest
Blog
Feb 21, 2025, 14:13
Rachel Chown: An incredibly inspiring and humbling talk from Liubov Lisovska
Science
Feb 21, 2025, 14:08
Survival improvement of patients with melanoma brain or leptomeningeal metastases in Denmark - CCIT-DK
Science
Feb 21, 2025, 13:51
Aaron Sverdlov: Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities
Blog
Feb 21, 2025, 13:40
Breaking barriers: ensuring equal cancer care access for diverse communities - SPCC
Blog
Feb 21, 2025, 13:29
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society's SABCS